Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 796. The contact email is not on this page.
- FLOURISH COLLECTIVE INC
NIH R43: AI-Driven Risk Prediction and Action Platform to Reduce Maternal Health Risks Among Expecting Mothers Enrolled in Medicaid
startup · RI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TOOMER THERAPEUTICS, INC.
NIH R41: Development of ARIH1 inhibitors as a novel targeted therapy in cancer
startup · SC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Bondwell Technologies LP
Form D history: Biotechnology
startup · TX · amount not stated · 2023-11-16
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-11-16.
- MEADOWLARK OPTICS, INC.
NIH R44: Improving Speed and Cost of Entry for Holographic Optogenetics
startup · CO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- IMMUNOGENIC CANCER ENGINEERING THERAPEUTICS LLC
NIH R41: Development of MCL 1-Targeting Antibody–Drug Conjugates for Cancer Therapy
startup · NJ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AIRALUX MEDICAL, INC.
NIH R43: DIGITAL INCENTIVE SPIROMETRY EXERCISER TO IMPROVE PATIENT ADHERENCE AND CLINICAL WORKFLOWS
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ADEPTHERA, LLC
NIH R43: Regenerative peptide therapy to accelerate pressure ulcer healing
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CAMELLIX, LLC
NIH R41: EC16 Nanoparticles: Bridging Oral Health and Alzheimer's Prevention via FAST Nanotechnology
startup · GA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NOVUS VISION LLC
NIH R44: Pharmaceutical development of longer-lasting brimonidine eye drops
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RNA THERAPEUTICS INC.
NIH R41: Development of a Pan-COVID-19 Vaccine Candidate
startup · DE · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PUMPKINSEED TECHNOLOGIES INC
NIH R43: Dynamic, live-cell monitoring of T-cell states against presented peptides
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- DRINKSAVVY, INC.
NIH R44: Development of a Colorimetric Sensor for Detection of Cerebrospinal Fluid Leaks
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VASARYA THERAPEUTICS, INC.
NIH R44: Translating a Novel Therapeutic Approach to the Treatment for Idiopathic Pulmonary Fibrosis
startup · DE · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MILLION MARKER WELLNESS INC.
NIH R43: Development of an Environmental Health Literacy Mobile Application to Reduce Toxic Environmental Exposures in Black Communities
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BrainCheck
BrainCheck is a digital neurocognitive platform that supports longitudinal cognitive care across clinical and research settings, providing tools for screening, assessment, and care planning.
startup · TX · amount not stated · 2024-01-05
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-01-05.
- IMMUNOGENIK, INC.
NIH R41: Advancing cancer therapy: Developing antibody blockade targeting a novel immune checkpoint, LAIR1/CD305
startup · FL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CG SCIENTIFIC, INC.
NIH R44: Low-Cost Platform Technology for Rapid Isolation of Peripheral Blood Mononuclear Cells
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- FOLI BIO INC.
NIH R43: Development of fecal exfoliome sequencing as a multi-omics approach for gut health management
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LABSYS, LLC
NIH R43: Wearable Continuous Drug Monitoring Device for Personal Medications in Opioid Use Disorders (CDM-MOUD)
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TING THERAPEUTICS, INC.
NIH R44: CDK2 inhibitors for protecting hearing loss
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MEMBRANE SCIENCES, LLC
NIH R44: Development of a Kit for Profiling Unbound Free Fatty Acids
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ANTIXERO
NIH R43: AntiXero: An extended duration solution for cancer-associated dry mouth.
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GATEWAY BIO, INC.
NIH R44: Scale-up and Toxicity Studies of POEGMA-Uricase
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SMART BREAST CORPORATION D/B/A SMART BREAST CORP
NIH R44: Commercial-Ready Molecular Breast Imaging (MBI) for Biopsy Guidance
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NOVOBIOTIC PHARMACEUTICALS, LLC
NIH R44: Teixobactin Development for Tuberculosis
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ACROBAT GENOMICS, INC.
NIH R43: High-throughput optimization of gene editing systems for treating Amyotrophic lateral sclerosis
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MONTANA MOLECULAR, LLC
NIH R43: Fluorescent Biosensors for measuring the signaling kinetics of GPCR ligands that activate G12/13 pathways.
startup · MT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- JAN BIOTECH, INC.
NIH R44: Clinical Assay to Accurately Profile and Monitor the HIV-1 Reservoir in Chronic-treated Individuals to Guide Treatment Decisions
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- COLLAGEN MEDICAL, LLC
NIH R44: Theranostic for gastric cancer
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GOOD NUTRITION IDEAS, LLC
NIH R43: HOMEals: A Science-Based Clinical Decision Support System for Nutrition in IDD Group Homes
startup · OR · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AIVOCODE, LLP
NIH R44: Single domain antibody development for improving vascular dysfunction in Alzheimer’s disease
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SHY THERAPEUTICS, LLC
NIH R43: Development of a Novel Class of Antifungal Therapy
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Inhalon Biopharma, Inc.
Form D history: Biotechnology
startup · NC · amount not stated · 2020-09-17
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2020-09-17.
- RERX THERAPEUTICS, INC
NIH R44: Evaluation of novel small molecule targeting lipid and energy homeostasis for treating obesity
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CELLFORMA, INC
NIH R43: Development of Novel Regenerative Cell Therapies for Lung Diseases using AI-guided Chemical Reprogramming of Human Cells
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GENERAL ENGINEERING AND RESEARCH, LLC
NIH R41: Personal Cooling Garments to Protect at-Risk Patients from Extreme Heat Waves
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MERAKRIS THERAPEUTICS INC
NIH R44: Evaluation of Efficacy and Safety of MTX-001 in Diabetic Foot Ulcers
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GENERAL BIOPHYSICS, LLC
NIH R43: Xenon Gas Preservation of Refrigerated Platelets
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TYMORA ANALYTICAL OPERATIONS, LLC
NIH R44: Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease
startup · IN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PHARYNVAC SURGICAL TECHNOLOGY INC.
NIH R41: Development of a novel kit for reduction of aerosolized particles during endonasal surgeries: the PharynVac Device
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.